GNI Ltd. Announces Approval for TSE Mothers Market Listing

TOKYO--(BUSINESS WIRE)--GNI Ltd., a biopharmaceutical company in Asia, announced that the Company received approval today from the Tokyo Stock Exchange Inc. (“TSE”) to list its shares on the Mothers market of the TSE.

MORE ON THIS TOPIC